PRE MARKET
Gift Nifty indicates a flat to negative start for the broader index in India, with a loss of 30.5 points or 0.12 percent. The Nifty futures were trading around the 25,423 level.
The US indices faced a volatile week, due to heavyweight technology and communications services shares losing ground on nagging fears of disruption by artificial intelligence.
The Dow Jones Industrial Average rose 48.95 points, or 0.10%, to 49,500.93, the S&P 500 gained 3.41 points, or 0.05%, to 6,836.17, and the Nasdaq Composite lost 50.48 points, or 0.22%, to 22,546.67.
For the week, the S&P 500 fell 1.39%, the Nasdaq declined 2.1%, and the Dow fell 1.23% for their biggest weekly losses since November.
Asian shares were quietly consolidating recent hefty gains on Monday as holidays made for thin trading, and dismal economic data out of Japan took some of the heat out of that booming market.
Japan’s Nikkei, Singapore’s Straits Times, and Hong Kong’s Hang Seng, indicated a negative start with -0.12, -0.0,6 and -0.03 percent respectively.
STOCKS IN NEWS
Manappuram Finance
The Reserve Bank of India (RBI) has granted its final approval for the proposed acquisition of control and shareholding of up to 41.66% of the paid-up equity capital/convertible instruments of Manappuram Finance by BC Asia Investments XXV and BC Asia Investments XIV.
Lodha Developers
The company has entered into a Share Purchase Agreement to acquire an 80% stake in Solidrise Realty (SRPL) for Rs 294 crore. Following this, SRPL will become a subsidiary of the company. SRPL is engaged in the real estate business in Pune.
Hindustan Copper
The Government of Jharkhand has issued a demand notice for the recovery of a compensation amount of Rs 929.4 crore from Hindustan Copper, alleging that the company undertook production from the Surda mine without valid statutory clearances or in excess of permissible limits during the period from FY2000-01 to FY2016-17. The company denies the allegations and is taking appropriate legal actions in this regard.
Ashoka Buildcon
The company has received a Letter of Acceptance from the Ministry of Public Works, Liberia, for a project worth $45.27 million. The project involves upgrading the road from Nrowkia (Sasstown Junction) to Barclayville, Nrowkia (Sasstown Junction) to Sasstown, and part of the Nrowkia (Sasstown Junction) to Nipleppo road project in the Republic of Liberia.
Aurobindo Pharma
The company’s subsidiary, Acrotech Biopharma Inc., announced that the US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ADQUEY (difamilast 1%) ointment. ADQUEY is used for the topical treatment of mild-to-moderate atopic dermatitis (AD) in adults and pediatric patients aged two years and older.
Natco Pharma
The company has received approval for Semaglutide from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide injection in India. Natco will launch the product in the Indian market in March 2026. Semaglutide is used for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
Source – Moneycontrol
